maresin1通过Nrf2/SLC7A11/GPX4途径抑制铁死亡,以预防脓毒症诱导的急性肝损伤。
Maresin1 Inhibits Ferroptosis via the Nrf2/SLC7A11/GPX4 Pathway to Protect Against Sepsis-Induced Acute Liver Injury.
作者信息
Guo Yongjing, Chen Huimin, Sun Jian, Zhang Jingxiao, Yin Yongjie
机构信息
Department of Emergency and Critical Care, The Second Hospital of Jilin University, Changchun, 130021, People's Republic of China.
Department of Pediatric Surgery, The Second Hospital of Jilin University, Changchun, 130021, People's Republic of China.
出版信息
J Inflamm Res. 2024 Dec 13;17:11041-11053. doi: 10.2147/JIR.S498775. eCollection 2024.
PURPOSE
Maresin 1 (MaR1) is a specialized pro-resolving mediator with anti-inflammatory properties that promotes tissue repair. This study aims to investigate the molecular involvement of MaR1 in protecting against sepsis-induced acute liver injury (SI-ALI).
METHODS
In vivo, a murine SI-ALI model was established using the cecal ligation and puncture (CLP) paradigm, providing a system in which the mechanistic functions of MaR1 could be tested. These analyses were supplemented through in vitro assays in which Alpha mouse liver 12 (AML12) hepatocytes and RAW264.7 macrophages were co-cultured in a Transwell system, with lipopolysaccharide (LPS) stimulation being used to establish a sepsis model. These cells were treated with MaR1 and/or nuclear factor erythroid 2-related factor 2 (Nrf2)inhibitor, while lentiviral transduction was used to knock down Nrf2 within AML12 cells. Hepatic pathological damage was assessed through hematoxylin and eosin staining. Lipid peroxidation-related analyses were conducted through the use of thiobarbituric acid, ferrous ions, glutathione, and appropriate fluorescent probes for reactive oxygen species detection. Liver enzymes and inflammatory mediators were quantified using appropriate Enzyme-Linked Immunosorbent Assays (ELISAs). Protein concentrations were evaluated via Western blot analysis.
RESULTS
The presence of ferroptosis in SI-ALI. MaR1 was found to proficiently suppress ferroptosis in SI-ALI. Mechanistically, MaR1 enhanced Nrf2 expression in AML12 hepatocytes, while the Nrf2 inhibitor ML-385 or Nrf2 siRNA mitigated MaR1's regulatory influence on ferroptosis. Meanwhile, the expressions of the downstream genes solute carrier family 7 member 11 (SLC7A11) and glutathione peroxidase 4 (GPX4) diminished, suggesting that MaR1 has a protective function via activating the Nrf2/SLC7A11/GPX4 pathway to mitigate ferroptosis in septic liver injury.
CONCLUSION
The results indicate that MaR1 mitigates SI-ALI via stimulating the Nrf2/SLC7A11/GPX4 pathway to suppress ferroptosis. Moreover, it offers significant potential as a new agent for the prevention of SI-ALI.
目的
maresin 1(MaR1)是一种具有抗炎特性的促消退介质,可促进组织修复。本研究旨在探讨MaR1在预防脓毒症诱导的急性肝损伤(SI-ALI)中的分子机制。
方法
在体内,采用盲肠结扎和穿刺(CLP)范式建立小鼠SI-ALI模型,以提供一个可测试MaR1机制功能的系统。通过体外实验进行补充分析,其中Alpha小鼠肝脏12(AML12)肝细胞和RAW264.7巨噬细胞在Transwell系统中共培养,使用脂多糖(LPS)刺激建立脓毒症模型。这些细胞用MaR1和/或核因子红细胞2相关因子2(Nrf2)抑制剂处理,同时使用慢病毒转导敲低AML12细胞中的Nrf2。通过苏木精和伊红染色评估肝脏病理损伤。通过使用硫代巴比妥酸、亚铁离子、谷胱甘肽和用于活性氧检测的适当荧光探针进行脂质过氧化相关分析。使用适当的酶联免疫吸附测定(ELISA)对肝酶和炎症介质进行定量。通过蛋白质印迹分析评估蛋白质浓度。
结果
SI-ALI中存在铁死亡。发现MaR1能有效抑制SI-ALI中的铁死亡。机制上,MaR1增强了AML12肝细胞中Nrf2的表达,而Nrf2抑制剂ML-385或Nrf2 siRNA减轻了MaR1对铁死亡的调节作用。同时,下游基因溶质载体家族7成员11(SLC7A11)和谷胱甘肽过氧化物酶4(GPX4)的表达降低,表明MaR1通过激活Nrf2/SLC7A11/GPX4途径具有保护作用,以减轻脓毒症肝损伤中的铁死亡。
结论
结果表明,MaR1通过刺激Nrf2/SLC7A11/GPX4途径减轻SI-ALI,抑制铁死亡。此外,它作为预防SI-ALI的新药具有巨大潜力。